XTNT Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (XTNT) is expected to report earnings on November 10, 2026, before the market open.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. Xtant Medical Holdings, Inc., formerly known as Bacterin International Holdings, Inc., is based in Belgrade, United States.
Sector
Healthcare